| 일자 | 시간 | 출처 | 헤드라인 | 심볼 | 기업 |
| 2017/02/14 | 21:02 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/09/09 | 22:06 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/09/06 | 19:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/09/03 | 04:30 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/09/02 | 07:03 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/09/02 | 07:02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/09/01 | 07:28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/09/01 | 07:28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/09/01 | 07:28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/09/01 | 07:28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/09/01 | 07:28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/09/01 | 07:28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/09/01 | 07:28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/09/01 | 07:28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/09/01 | 07:28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/09/01 | 07:28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/09/01 | 07:28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/09/01 | 07:27 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/08/31 | 03:56 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/08/31 | 03:51 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/08/30 | 05:18 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/08/30 | 05:12 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/08/30 | 02:17 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/08/29 | 20:58 | Business Wire | Nichi-Iko Pharmaceutical Co., Ltd. Announces Results of Tender Offer to Purchase All of the Outstanding Shares of Common Stoc... | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/08/29 | 19:17 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/08/24 | 22:23 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/08/23 | 06:51 | PR Newswire (US) | Chemical Financial Set to Join S&P MidCap 400; Supervalu, Shoe Carnival and Eagle Pharmaceuticals to Join S&P SmallCap 600 | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/08/22 | 19:10 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/08/19 | 05:56 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 2016/08/19 | 05:39 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |